Lupin surges on the bourses

08 Jul 2020 Evaluate

Lupin is currently trading at Rs. 884.70, up by 13.90 points or 1.60% from its previous closing of Rs. 870.80 on the BSE.

The scrip opened at Rs. 876.00 and has touched a high and low of Rs. 889.15 and Rs. 865.00 respectively. So far 68138 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 955.85 on 15-Jun-2020 and a 52 week low of Rs. 505.00 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 912.95 and Rs. 865.00 respectively. The current market cap of the company is Rs. 39323.77 crore.

The promoters holding in the company stood at 46.92%, while Institutions and Non-Institutions held 39.23% and 13.85% respectively.

Lupin is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg products to the consumer level in the U.S. This recall is being conducted out of an abundance of caution in line with the ongoing interaction with the U.S. Food and Drug Administration on NDMA impurity levels. Lupin’s U.S. subsidiary Lupin Pharmaceuticals Inc. distributes Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg in the U.S.

The company’s Metformin products manufactured and marketed in India have been tested for NDMA levels and have been assessed to be safe for patients and comply with all relevant regulatory norms.

Lupin is an innovation led transnational pharmaceutical company headquartered in Mumbai, India.

 

Lupin Share Price

1609.85 25.60 (1.62%)
10-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1505.20
Dr. Reddys Lab 5922.45
Cipla 1339.45
Zydus Lifesciences 983.05
Lupin 1609.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.